다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BOLD

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2018/11/07	07:31	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:BOLD	Boundless Bio Inc
2018/11/07	06:53	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2018/11/07	06:01	PR Newswire (US)	Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update	NASDAQ:BOLD	Boundless Bio Inc
2018/11/05	22:00	PR Newswire (US)	Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman	NASDAQ:BOLD	Boundless Bio Inc
2018/10/30	21:00	PR Newswire (US)	Audentes Therapeutics to Release Third Quarter 2018 Financial Results and Provide Corporate Update on Tuesday, November 6, 20...	NASDAQ:BOLD	Boundless Bio Inc
2018/10/30	05:09	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BOLD	Boundless Bio Inc
2018/10/12	05:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2018/10/12	05:16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:BOLD	Boundless Bio Inc
2018/10/11	09:30	PR Newswire (US)	Audentes Therapeutics Announces Pricing of Public Offering of Common Stock	NASDAQ:BOLD	Boundless Bio Inc
2018/10/10	23:06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/10/10	05:30	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:BOLD	Boundless Bio Inc
2018/10/10	05:20	PR Newswire (US)	Audentes Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:BOLD	Boundless Bio Inc
2018/10/05	21:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BOLD	Boundless Bio Inc
2018/10/05	21:01	PR Newswire (US)	Audentes Therapeutics to Provide Update on New Positive Interim Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Pa...	NASDAQ:BOLD	Boundless Bio Inc
2018/10/05	21:00	PR Newswire (US)	Audentes Therapeutics Presents New Positive Interim Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with ...	NASDAQ:BOLD	Boundless Bio Inc
2018/10/03	22:00	PR Newswire (US)	Audentes Therapeutics Announces Co-Founder and Chief Executive Officer Matthew R. Patterson Appointed Chairman of the Allianc...	NASDAQ:BOLD	Boundless Bio Inc
2018/10/03	08:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2018/10/03	08:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2018/10/03	08:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2018/09/27	08:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2018/09/26	21:00	PR Newswire (US)	Audentes Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BOLD	Boundless Bio Inc
2018/09/25	07:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2018/09/24	21:00	PR Newswire (US)	Audentes Therapeutics to Present New Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotub...	NASDAQ:BOLD	Boundless Bio Inc
2018/09/21	08:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BOLD	Boundless Bio Inc
2018/09/10	23:05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/08/29	21:00	PR Newswire (US)	Audentes Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BOLD	Boundless Bio Inc
2018/08/21	21:00	PR Newswire (US)	Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of...	NASDAQ:BOLD	Boundless Bio Inc
2018/08/11	05:32	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/08/11	05:23	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:BOLD	Boundless Bio Inc
2018/08/09	21:00	PR Newswire (US)	Audentes Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference	NASDAQ:BOLD	Boundless Bio Inc

검색 관련기사 보기:NASDAQ:BOLD

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

Energy Select Sector SPDR

JP Morgan Chase

BNP Paribas (QX)

US Dollar vs Euro

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관